@article {Kurita2020.04.02.20051490, author = {Junko Kurita and Tamie Sugawara and Yasushi Ohkusa}, title = {Forecast of the COVID-19 outbreak and effects of self-restraint in going out in Tokyo, Japan}, elocation-id = {2020.04.02.20051490}, year = {2020}, doi = {10.1101/2020.04.02.20051490}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background The number of patients of COVID-19 in Tokyo has been increasing gradually through the end of March, 2020.Object Support for policymaking requires forecasting of the entire course and outcome of the outbreak if a self-restraint in going out is not initiated. Moreover, the effects of a self-restraint in going out must be considered when choosing to initiate one. Method: Data of Tokyo patients with symptoms during January 14 {\textendash} March 28, 2020 were used to formulate a susceptible{\textendash}infected{\textendash}recovered (SIR) model using three age classes and to estimate the basic reproduction number (R0). Based on the estimated R0, We inferred outbreak outcomes and medical burden if a self-restraint in going out were not enacted. Then we estimate the self-restraint in going out effects.Results Results suggest R0 as 2.86, with a 95\% confidence interval of [2.73, 2.97]. Exhaustion of medical resources can be expected to occur on April 26 if no self-restraint in going out occurs. If a self-restraint in going out were enacted from April 6, and if more than 60\% of trips outside the home were restricted voluntarily, then medical care service could be maintained.Discussion and Conclusion The estimated R0 was similar to that found from other studies conducted in China and Japan. Results demonstrate that a self-restraint in going out with reasonable cooperation of residents is required to maintain medical care.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe author(s) received no specific funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesJapan Ministry of Health, Labour and Welfare. Press Releases of Domestic Situation (in Japanese) https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_00086.html}, URL = {https://www.medrxiv.org/content/early/2020/05/13/2020.04.02.20051490}, eprint = {https://www.medrxiv.org/content/early/2020/05/13/2020.04.02.20051490.full.pdf}, journal = {medRxiv} }